Approved dataset
Coverage counts only source-supported estimates approved for the product. Linked listings roll up to one canonical issuer in headline totals, while the exchange table retains listing identity.
Beta freshness boundary · reviewed
Beta coverage includes the reviewed, approved statements published in the product. Each figure keeps its own effective date and source publication date. Coverage varies by issuer, and a covered company may have newer disclosures awaiting review.
At this review, recent ASX, SEC and TSX announcement checks include incomplete source windows. Previously reviewed statements can remain visible while newer sources are checked. Unresolved figures remain withheld; updates appear after source review and approval.
Use each figure’s Evidence to check its source and statement date. The newest date below applies only to the newest covered source or statement. The sample generation time on the home page records when that view refreshed; it does not establish current coverage for every issuer.
Canonical issuers
528 / 1926
27% covered
Covered projects
1369
with approved R&R
Approved estimates
28826
includes historical vintages
Supporting documents
854
distinct primary sources
| Exchange | Active | Covered | Rate |
|---|---|---|---|
| AIM | 95 | 23 | 24% |
| ASX | 773 | 234 | 30% |
| LSE | 8 | 8 | 100% |
| NASDAQ | 47 | 21 | 45% |
| NYSE | 111 | 65 | 59% |
| TSX | 178 | 94 | 53% |
| TSXV | 833 | 163 | 20% |
See how statement vintages, reporting basis and evidence are handled, or apply to explore the full dataset.